Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingxia Fan

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
Nature Communications|March 25, 2017
High-performance and compact-designed flexible thermoelectric modules enabled by a reticulate carbon nanotube architectureWenbin Zhou, Qingxia Fan, Qiang Zhang, et al.
The Oncologist|May 18, 2021
Treatment Patterns and Outcomes in Chinese Patients with Gastric Cancer by HER2 Status: A Noninterventional Registry Study (EVIDENCE)Shukui Qin, Jiafu Ji, Rui-Hua Xu, et al.
BMC Cancer|February 10, 2016
Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trialJifang Gong, Tianshu Liu, Qingxia Fan, et al.
Nanoscale|November 9, 2013
Temperature dependent Raman spectra of isolated suspended single-walled carbon nanotubesXiao Zhang, Feng Yang, Duan Zhao, et al.
Oncotarget|March 26, 2016
Predictive value of EGFR overexpression and gene amplification on icotinib efficacy in patients with advanced esophageal squamous cell carcinomaXi Wang, Haitao Niu, Qingxia Fan, et al.
Oncotarget|September 9, 2017
Transgenic overexpression of NanogP8 in the mouse prostate is insufficient to initiate tumorigenesis but weakly promotes tumor development in the Hi-Myc mouse modelBigang Liu, Shuai Gong, Qiuhui Li, et al.
Investigational New Drugs|January 30, 2025
Anti-PD-L1 envafolimab combined with anti-VEGF suvemcitug in pretreated solid tumors and hepatocellular carcinoma: an open-label phase II study with safety run-in stageLixia Ma, Yu Zhang, Yong Fang, et al.
Biochemical Pharmacology|January 12, 2011
FNC, a novel nucleoside analogue inhibits cell proliferation and tumor growth in a variety of human cancer cellsQiang Wang, Xiaobing Liu, Qingduan Wang, et al.
Experimental Cell Research|November 26, 2013
Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinomaDongli Yue, Qingxia Fan, Xinfeng Chen, et al.
International Journal of Colorectal Disease|January 21, 2025
The efficacy and safety of suvemcitug, envafolimab, and FOLFIRI in microsatellite-stable or mismatch repair-proficient colorectal cancer: preliminary results of a phase 2 studyYing Liu, Jufeng Wang, Yong Fang, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Nature Communications|March 25, 2017
High-performance and compact-designed flexible thermoelectric modules enabled by a reticulate carbon nanotube architectureWenbin Zhou, Qingxia Fan, Qiang Zhang, et al.
The Oncologist|May 18, 2021
Treatment Patterns and Outcomes in Chinese Patients with Gastric Cancer by HER2 Status: A Noninterventional Registry Study (EVIDENCE)Shukui Qin, Jiafu Ji, Rui-Hua Xu, et al.
BMC Cancer|February 10, 2016
Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trialJifang Gong, Tianshu Liu, Qingxia Fan, et al.
Nanoscale|November 9, 2013
Temperature dependent Raman spectra of isolated suspended single-walled carbon nanotubesXiao Zhang, Feng Yang, Duan Zhao, et al.
Oncotarget|March 26, 2016
Predictive value of EGFR overexpression and gene amplification on icotinib efficacy in patients with advanced esophageal squamous cell carcinomaXi Wang, Haitao Niu, Qingxia Fan, et al.
Oncotarget|September 9, 2017
Transgenic overexpression of NanogP8 in the mouse prostate is insufficient to initiate tumorigenesis but weakly promotes tumor development in the Hi-Myc mouse modelBigang Liu, Shuai Gong, Qiuhui Li, et al.
Investigational New Drugs|January 30, 2025
Anti-PD-L1 envafolimab combined with anti-VEGF suvemcitug in pretreated solid tumors and hepatocellular carcinoma: an open-label phase II study with safety run-in stageLixia Ma, Yu Zhang, Yong Fang, et al.
Biochemical Pharmacology|January 12, 2011
FNC, a novel nucleoside analogue inhibits cell proliferation and tumor growth in a variety of human cancer cellsQiang Wang, Xiaobing Liu, Qingduan Wang, et al.
Experimental Cell Research|November 26, 2013
Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinomaDongli Yue, Qingxia Fan, Xinfeng Chen, et al.
International Journal of Colorectal Disease|January 21, 2025
The efficacy and safety of suvemcitug, envafolimab, and FOLFIRI in microsatellite-stable or mismatch repair-proficient colorectal cancer: preliminary results of a phase 2 studyYing Liu, Jufeng Wang, Yong Fang, et al.
Pageof 11